Biodistribution for
Gene & Cell Therapy
Gene and cell therapies represent transformative approaches for treating ophthalmic diseases, requiring specialized preclinical evaluation of biodistribution, safety, and efficacy to ensure successful translation.
These advanced modalities demand precise characterization of ocular tissue targeting and vector distribution. Powered Research provides biodistribution studies for gene and cell therapies across multiple routes of administration, leveraging our expertise as a non-GLP ophthalmology CRO.
Cell Therapy
Our team is equipped to evaluate novel cell therapy strategies in ophthalmology and beyond. We specialize in the precise delivery of cell-based materials and detailed analysis of viability and efficacy in your experimental model.
Gene Therapy
We offer services for evaluating novel gene therapy techniques. Our approach includes precise vector delivery and deep characterization of transgene expression and efficacy in your experimental model.